|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Aurora kinase inhibitors 显示文摘 | KITZEN J J DEJONGE M J VERWEIJ J | 2010 | Crit Rev Oncol /Hematol2010，73，2： | 1 |
| 2 | The relevance of microdialysis for clinical on:cology 显示文摘 | Kitzen J J Verweij J Wiemer EA | 2006 | Curr Clin Pharmacol2006，1，3： | 1 |
| 3 | Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours显示文摘 | De Jonge MJ Dumez H Kitzen JE | | 0，，09： | 1 |
| 4 | Aurora kinase inhibitors显示文摘 | KITZEN J de JONGE M J A VERWEIJ J | 2010 | Crit Rev Oncol Hemat2010，73，2： | 1 |
| 5 | Aurora kinase inhibitors 显示文摘 | KITZEN J J DEJONGE M J VERWEIJ J | 2010 | Crit Rev Oneall Hematol2010，73，2： | 1 |
| 6 | Phase Ⅰ dose-escalation study of F60008,a novel apoptosis inducer,in patients with advanced solid tumours显示文摘 | Kitzen JJ de Jonge MJ Lamers CH | | 0，，10： | 1 |
| 7 | A phase Ib study of pertuzumab, a re- combinant humanized antibody to HER2,anddocetaxel in patients with advanced solid tumours 显示文摘 | G Attard J Kitzen SP Blagden | 2007 | British Journal of Cancer2007，97，： | 1 |
| 8 | Aurora kinase inhibitors显示文摘 | Kitzen JJ de Jonge MJ Verweij J | 2010 | Crit Rev Oncol Hematol2010，73，2： | 1 |
| 9 | Phase ! safety, pharmacoki- netic, and pharmacogenomic trial of ES-285, a novel marine cy- totoxic agent, administered to adult patients with advanced solid tumors显示文摘 | Baird RD Kitzen J Clarke PA | 2009 | Mol Cancer Ther2009，8，6： | 1 |
| 10 | Phase I dose-escalation study of F60008,a novel apoptosis inducer,in patients with advanced solid tumours显示文摘 | Kitzen JJ de Jonge MJ Lamers CH Eskens FA vander Biessen D van Doom L | 2009 | Eur J Cancer2009，45，10： | 1 |
| 11 | Aurora kinase inhibitors 显示文摘 | Kitzen J J de Jonge M J Verweij J | 2010 | Crit Rev OncolHematol2010，73，2： | 1 |
| 12 | Aurora kinase inhibitors显示文摘 | Kitzen JJ de Jonge M J Verweij J | | 0，，02： | 1 |
| 13 | Enhancement of exopolysaccharide production by Lactobacillus delbrueckii subsp, bulgaricus NCFB 2772 with a simplified defined medium显示文摘 | Grobben GJ Chin-Joe I Kitzen VA | 1998 | Applied and Environmental Microbiology1998，54，： | 1 |
| 14 | A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours 显示文摘 | Attard G Kitzen J Blagden SP | 2007 | Br J Cancer2007，97，10： | 1 |
| 15 | Aurora kinase inhibitors显示文摘 | Kitzen JJ de Jonge MJ Verweij J | | 0，，02： | 1 |
| 16 | Potassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine显示文摘 | Kitzen JM McCallum JD Harvey C | 1992 | Pharmacology1992，45，2： | 1 |
| 17 | Aurora kinase inhibitors显示文摘 | Kitzen JJ de Jonge MJ | | 0，，02： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员